Shenzhen Net Income From Continuing Ops from 2010 to 2024

300942 Stock   8.48  0.50  5.57%   
Shenzhen Bioeasy's Net Loss is decreasing over the years with slightly volatile fluctuation. Overall, Net Loss is projected to go to about -175.7 M this year. From 2010 to 2024 Shenzhen Bioeasy Net Loss quarterly data regression line had arithmetic mean of  63,116,577 and r-squared of  0.22. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-185 M
Current Value
-175.7 M
Quarterly Volatility
106.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Shenzhen Bioeasy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shenzhen Bioeasy's main balance sheet or income statement drivers, such as Tax Provision of 14 M, Interest Expense of 11.2 M or Selling General Administrative of 76.7 M, as well as many indicators such as . Shenzhen financial statements analysis is a perfect complement when working with Shenzhen Bioeasy Valuation or Volatility modules.
  
This module can also supplement various Shenzhen Bioeasy Technical models . Check out the analysis of Shenzhen Bioeasy Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Shenzhen Stock

Shenzhen Bioeasy financial ratios help investors to determine whether Shenzhen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shenzhen with respect to the benefits of owning Shenzhen Bioeasy security.